54 related articles for article (PubMed ID: 19916705)
21. An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study.
Aas AM; Bergstad I; Thorsby PM; Johannesen O; Solberg M; Birkeland KI
Diabet Med; 2005 Mar; 22(3):316-22. PubMed ID: 15717881
[TBL] [Abstract][Full Text] [Related]
22. Starting or switching to biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes: a multicenter, observational, primary care study conducted in Finland.
Mäkelä JK; Schmüser C; Askonen K; Saukkonen T
Diabetes Res Clin Pract; 2012 Jan; 95(1):10-8. PubMed ID: 22078072
[TBL] [Abstract][Full Text] [Related]
23. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study.
Home P; Naggar NE; Khamseh M; Gonzalez-Galvez G; Shen C; Chakkarwar P; Wenying Y
Diabetes Res Clin Pract; 2011 Dec; 94(3):352-63. PubMed ID: 22153567
[TBL] [Abstract][Full Text] [Related]
24. The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes: an open-label, non-randomised, multi-centre observational study--the Iran subgroup of the IMPROVE™ study.
Esteghamati A; Rajabian R; Amini M; Bahrami A; Khamseh ME; Afkhami-Ardekani M; Rizi EP
Endokrynol Pol; 2010; 61(4):364-70. PubMed ID: 20806180
[TBL] [Abstract][Full Text] [Related]
25. The IMPROVE study--a multinational, observational study in type 2 diabetes: data from the Polish cohort.
Gumprecht J; Zurawska G; Wolnik B; Dzida G
Endokrynol Pol; 2008; 59(6):460-6. PubMed ID: 19347809
[TBL] [Abstract][Full Text] [Related]
26. Effect of biphasic insulin aspart on glucose and lipid control in patients with Type 2 diabetes mellitus.
Lalić NM; Micić D; Antić S; Bajović L; Pantelinac P; Jotić A; Kendereski A; Dimić D; Djukić A; Mitrović M; Vujasin M
Expert Opin Pharmacother; 2007 Dec; 8(17):2895-901. PubMed ID: 18001251
[TBL] [Abstract][Full Text] [Related]
27. Assessment of quality of life in patients with type 2 diabetes mellitus before and after starting biphasic insulin aspart 30 (BIAsp 30) therapy: IMPROVE study in Japan.
Ishii H; Iwase M; Seino H; Shuto Y; Atsumi Y
Curr Med Res Opin; 2011 Mar; 27(3):643-50. PubMed ID: 21250861
[TBL] [Abstract][Full Text] [Related]
28. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life.
Pollack MF; Purayidathil FW; Bolge SC; Williams SA
Diabetes Res Clin Pract; 2010 Feb; 87(2):204-10. PubMed ID: 20036433
[TBL] [Abstract][Full Text] [Related]
29. Improvements in quality of life associated with insulin analogue therapies in people with type 2 diabetes: results from the A1chieve observational study.
Shah S; Zilov A; Malek R; Soewondo P; Bech O; Litwak L
Diabetes Res Clin Pract; 2011 Dec; 94(3):364-70. PubMed ID: 22153568
[TBL] [Abstract][Full Text] [Related]
30. Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results.
Güler S; Sharma SK; Almustafa M; Kim CH; Azar S; Danciulescu R; Shestakova M; Khutsoane D; Bech OM
Arch Drug Inf; 2009 Jun; 2(2):23-33. PubMed ID: 19684847
[TBL] [Abstract][Full Text] [Related]
31. Management of Chinese patients with type 2 diabetes, 1998-2006: the Diabcare-China surveys.
Pan C; Yang W; Jia W; Weng J; Tian H
Curr Med Res Opin; 2009 Jan; 25(1):39-45. PubMed ID: 19210137
[TBL] [Abstract][Full Text] [Related]
32. Use of a reference four-component model to define the effects of insulin treatment on body composition in type 2 diabetes: the 'Darwin study'.
Packianathan IC; Fuller NJ; Peterson DB; Wright A; Coward WA; Finer N
Diabetologia; 2005 Feb; 48(2):222-9. PubMed ID: 15688205
[TBL] [Abstract][Full Text] [Related]
33. Effect of dietary calcium intake on weight gain in type 2 diabetic patients following initiation of insulin therapy.
Duengler F; Torremocha F; Yameogo M; Marechaud R; Hadjadj S
Diabetes Metab; 2006 Sep; 32(4):358-63. PubMed ID: 16977264
[TBL] [Abstract][Full Text] [Related]
34. Course of body weight before and after the initiation of insulin therapy in type 2 diabetes mellitus: Retrospective inception cohort study (ZODIAC 58).
Edens MA; van Dijk PR; Hak E; Bilo HJG
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00212. PubMed ID: 33855214
[TBL] [Abstract][Full Text] [Related]
35. Insulin therapy does not itself induce weight gain in patients with type 2 diabetes.
Larger E; Rufat P; Dubois-Laforgue D; Ledoux S
Diabetes Care; 2001 Oct; 24(10):1849-50. PubMed ID: 11574460
[No Abstract] [Full Text] [Related]
36. Adjunctive prandial or biphasic insulin for type 2 diabetes improved glycaemic control but increased hypoglycaemia and weight gain.
Dinneen SF; Waldron-Lynch F
Evid Based Med; 2008 Jun; 13(3):77. PubMed ID: 18515624
[No Abstract] [Full Text] [Related]
37. Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes.
Luo Q; Zhou L; Zhou N; Hu M
Front Public Health; 2022; 10():1016937. PubMed ID: 36330105
[TBL] [Abstract][Full Text] [Related]
38. Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysis.
Czech M; Rdzanek E; Pawęska J; Adamowicz-Sidor O; Niewada M; Jakubczyk M
BMC Endocr Disord; 2015 Oct; 15():57. PubMed ID: 26458540
[TBL] [Abstract][Full Text] [Related]
39. Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings.
Liebl A; Prusty V; Valensi P; Kawamori R; Christiansen JS; Palmer AJ; Balschmidt P; Ligthelm R; Mohan V
Drugs; 2012 Jul; 72(11):1495-520. PubMed ID: 22818015
[TBL] [Abstract][Full Text] [Related]
40. Biphasic insulin aspart 30 as insulin initiation or replacement therapy: the China cohort of the IMPROVE study.
Yang W; Gao Y; Liu G; Chen L; Fu Z; Zou D; Feng P; Zhao Z
Curr Med Res Opin; 2010 Jan; 26(1):101-7. PubMed ID: 19916705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
